FXH Valuation

First Trust Health Care AlphaDEX (FXH) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of --. The fair price of First Trust Health Care AlphaDEX (FXH) is between -- to -- according to relative valuation method.

FXH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of First Trust Health Care AlphaDEX (FXH) is between -- to -- according to relative valuation method.

The average P/S ratio for FXH's competitors is 0.00, providing a benchmark for relative valuation. First Trust Health Care AlphaDEX Corp (FXH) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

As of Mar 05 2026, First Trust Health Care AlphaDEX (FXH) has a P/B ratio of NaN. This indicates that the market values FXH at NaN times its book value.

As of Mar 05 2026, First Trust Health Care AlphaDEX (FXH) has a FCF Yield of NaN%. This means that for every dollar of First Trust Health Care AlphaDEX's market capitalization, the company generates NaN cents in free cash flow.

As of Mar 05 2026, First Trust Health Care AlphaDEX (FXH) has a Forward P/E ratio of NaN. This means the market is willing to pay $NaN for every dollar of First Trust Health Care AlphaDEX's expected earnings over the next 12 months.

As of Mar 05 2026, First Trust Health Care AlphaDEX (FXH) has a Forward P/S ratio of NaN. This means the market is valuing FXH at $NaN for every dollar of expected revenue over the next 12 months.